# Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction

> **NCT06349031** · PHASE4 · UNKNOWN · sponsor: **Institute of Medical Sciences and SUM Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Functional Constipation
- Fecal Impaction
- Constipation - Functional
- Constipation Chronic Idiopathic
- Pediatric Functional Constipation

## Interventions

- **DRUG:** Administration of Polyethylene Glycol (PEG) 4000 as per treatment allocation to participants
- **DRUG:** Administration of Polyethylene Glycol (PEG) 3350 + Electrolyte as per treatment allocation to participants

## Key facts

- **NCT ID:** NCT06349031
- **Lead sponsor:** Institute of Medical Sciences and SUM Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-15
- **Primary completion:** 2024-09-15
- **Final completion:** 2024-09-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06349031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06349031, "Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06349031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*